To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.

Clinical Study of Biokinetic Model of Iodine-131 in Total(Near) Thyroidectomy Patients.

NCT03349294 ·Status: COMPLETED

Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

NCT05142904 ·Status: TERMINATED ·Phase: PHASE3

The TRUST Study - CardioVascular Imaging IMT

NCT02832934 ·Status: COMPLETED ·Phase: PHASE4

The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study

NCT01792492 ·Status: COMPLETED

Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy

NCT07124065 ·Status: ACTIVE_NOT_RECRUITING

Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration

NCT00196729 ·Status: COMPLETED ·Phase: PHASE3

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

NCT01398085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Hyperthyroid Follow-Up Study

NCT02989103 ·Status: COMPLETED

Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules

NCT03309631 ·Status: UNKNOWN

Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules

NCT01401855 ·Status: COMPLETED

Coexisting Thyroid Disease and Hyperparathyroidism

NCT01306916 ·Status: COMPLETED

Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

NCT05501041 ·Status: ENROLLING_BY_INVITATION

Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

NCT00001730 ·Status: COMPLETED ·Phase: PHASE4

Novel Approaches to the Treatment of Hypothyroidism

NCT06731764 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

NCT05229341 ·Status: RECRUITING ·Phase: NA

Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules

NCT02681328 ·Status: ACTIVE_NOT_RECRUITING

Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.

NCT06134830 ·Status: NOT_YET_RECRUITING

Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

NCT03498417 ·Status: COMPLETED

Pembrolizumab in High-risk Thyroid Cancer

NCT05852223 ·Status: RECRUITING ·Phase: PHASE2

Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3

NCT03488134 ·Status: COMPLETED

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

NCT07018323 ·Status: RECRUITING ·Phase: PHASE2

Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing

NCT06028282 ·Status: ENROLLING_BY_INVITATION

I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer

NCT01704586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules

NCT00316823 ·Status: COMPLETED ·Phase: NA

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

NCT03969108 ·Status: COMPLETED ·Phase: PHASE4